Table 3

Number of cases staining positively for anti-MUC1 monoclonal antibodies in tumour cells of ALK negative lymphomas

Lymphoma typeSM3VU-4H5DF3139H2E29
+++, 75–95% positive tumour cells; ++, 50–75% positive tumour cells; +/–, focal or scattered staining of <25% of tumour cells; –, no staining of tumour cells.
ALCL, anaplastic large cell lymphoma; DLBCL, diffuse large B cell lymphoma; HD-MC, Hodgkin's disease, mixed cellularity subtype; HD-NS, Hodgkin's disease, nodular sclerosing subtype;
PTCL-NOS, peripheral T cell lymphoma, not otherwise specified; T-LB, T lymphoblastic lymphoma.
ALK negative systemic ALCL3+/–3+/–3+/–
Primary cutaneous ALCL
Classic HD-NS1+++, 1+/–1++, 1+/–1+++, 1+/–
Classic HD-MC1+/–1+/–1+/–